The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.
The frequency of heterozygous protein C and protein S deficiency, detected by measuring total plasma antigen, in a group (n = 141) of young unrelated patients (less than 45 years old) with venous thrombotic disease was studied and compared to that of antithrombin III, fibrinogen, and plasminogen deficiencies. Among 91 patients not receiving oral anticoagulants, six had low protein S antigen levels and one had a low protein C antigen level. Among 50 patients receiving oral anticoagulant therapy, abnormally low ratios of protein S or C to other vitamin K-dependent factors were presented by one patient for protein S and five for protein C. Thus, heterozygous Type I protein S deficiency appeared in seven of 141 patients (5%) and heterozygous Type I protein C deficiency in six of 141 patients (4%). Eleven of thirteen deficient patients had recurrent venous thrombosis. In this group of 141 patients, 1% had an identifiable fibrinogen abnormality, 2% a plasminogen abnormality, and 3% an antithrombin III deficiency. Thus, among the known plasma protein deficiencies associated with venous thrombosis, protein S and protein C deficiencies (9%) emerge as the leading identifiable associated abnormalities.
Gladson
C L
CL
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California.
Scharrer
I
I
Hach
V
V
Beck
K H
KH
Griffin
J H
JH
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D006023:Glycoproteins / Q000172:deficiency* / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D008297:Male; D011486:Protein C / Q000235:genetics; D020151:Protein C Deficiency; D017293:Protein S; D013924:Thrombophlebitis / Q000097:blood / Q000235:genetics*
D000925:Anticoagulants; D006023:Glycoproteins; D011486:Protein C; D017293:Protein S